102 related articles for article (PubMed ID: 18824917)
1. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia.
Hållström L; Berghäll E; Frostell C; Sollevi A; Soop AL
Crit Care Med; 2008 Nov; 36(11):3043-7. PubMed ID: 18824917
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by a combination of nitric oxide and glucocorticoids in a human endotoxin model.
Hållström L; Berghäll E; Frostell C; Sollevi A; Soop AL
Acta Anaesthesiol Scand; 2011 Jan; 55(1):20-7. PubMed ID: 20825367
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia: It takes not always two to tango.
Pompe JC; Kox M; Hoedemaekers CW; van der Hoeven JG; Pickkers P
Crit Care Med; 2009 Sep; 37(9):2676; author reply 2676-7. PubMed ID: 19687652
[No Abstract] [Full Text] [Related]
4. Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis.
Da J; Chen L; Hedenstierna G
Crit Care Med; 2007 Jan; 35(1):26-32. PubMed ID: 17095945
[TBL] [Abstract][Full Text] [Related]
5. Adenosine infusion attenuates soluble RAGE in endotoxin-induced inflammation in human volunteers.
Soop A; Sundén-Cullberg J; Albert J; Hållström L; Treutiger CJ; Sollevi A
Acta Physiol (Oxf); 2009 Sep; 197(1):47-53. PubMed ID: 19302259
[TBL] [Abstract][Full Text] [Related]
6. Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma.
Jonasson S; Hedenstierna G; Hjoberg J
J Appl Physiol (1985); 2010 Aug; 109(2):521-31. PubMed ID: 20538845
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide does not influence cytokines or exhaled NO in human experimental endotoxaemia.
Soop A; Albert J; Weitzberg E; Bengtsson A; Nilsson CG; Sollevi A
Clin Exp Immunol; 2004 Jan; 135(1):114-8. PubMed ID: 14678271
[TBL] [Abstract][Full Text] [Related]
8. The effect of of glucocorticoids on grain dust-induced airway disease.
Trapp JF; Watt JL; Frees KL; Quinn TJ; Nonnenmann MW; Schwartz DA
Chest; 1998 Feb; 113(2):505-13. PubMed ID: 9498972
[TBL] [Abstract][Full Text] [Related]
9. Effects of carbon monoxide inhalation during experimental endotoxemia in humans.
Mayr FB; Spiel A; Leitner J; Marsik C; Germann P; Ullrich R; Wagner O; Jilma B
Am J Respir Crit Care Med; 2005 Feb; 171(4):354-60. PubMed ID: 15557136
[TBL] [Abstract][Full Text] [Related]
10. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin.
Bueno AC; Seahorn TL; Cornick-Seahorn J; Horohov DW; Moore RM
Am J Vet Res; 1999 Aug; 60(8):969-76. PubMed ID: 10451207
[TBL] [Abstract][Full Text] [Related]
11. Treatment With Acetylsalicylic Acid Reverses Endotoxin Tolerance in Humans In Vivo: A Randomized Placebo-Controlled Study.
Leijte GP; Kiers D; van der Heijden W; Jansen A; Gerretsen J; Boerrigter V; Netea MG; Kox M; Pickkers P
Crit Care Med; 2019 Apr; 47(4):508-516. PubMed ID: 30585832
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
[TBL] [Abstract][Full Text] [Related]
13. Organ dysfunction among piglets treated with inhaled nitric oxide and intravenous hydrocortisone during prolonged endotoxin infusion.
Göranson SP; Goździk W; Harbut P; Ryniak S; Zielinski S; Haegerstrand CG; Kübler A; Hedenstierna G; Frostell C; Albert J
PLoS One; 2014; 9(5):e96594. PubMed ID: 24827456
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.
Astiz ME; Rackow EC; Still JG; Howell ST; Cato A; Von Eschen KB; Ulrich JT; Rudbach JA; McMahon G; Vargas R
Crit Care Med; 1995 Jan; 23(1):9-17. PubMed ID: 8001393
[TBL] [Abstract][Full Text] [Related]
15. Adenosine treatment attenuates cytokine interleukin-6 responses to endotoxin challenge in healthy volunteers.
Soop A; Johansson C; Hjemdahl P; Kristiansson M; Gyllenhammar H; Li N; Sollevi A
Shock; 2003 Jun; 19(6):503-7. PubMed ID: 12785003
[TBL] [Abstract][Full Text] [Related]
16. Platelet dysfunction in a large-animal model of endotoxic shock; effects of inhaled nitric oxide and low-dose steroid.
Adamik B; Frostell C; Paslawska U; Dragan B; Zielinski S; Paslawski R; Janiszewski A; Zielinska M; Ryniak S; Ledin G; Gozdzik W
Nitric Oxide; 2021 Mar; 108():20-27. PubMed ID: 33400993
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.
Yeager MP; Rassias AJ; Pioli PA; Beach ML; Wardwell K; Collins JE; Lee HK; Guyre PM
Crit Care Med; 2009 Oct; 37(10):2727-32. PubMed ID: 19885996
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin-induced shock in the pig--limited effects of low and high concentrations of inhaled nitric oxide.
Middelveld RJ; Alving K
Acta Physiol Scand; 2003 Oct; 179(2):203-11. PubMed ID: 14510784
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response.
Kumar A; Zanotti S; Bunnell G; Habet K; Añel R; Neumann A; Cheang M; Dinarello CA; Cutler D; Parrillo JE
Crit Care Med; 2005 Feb; 33(2):331-40. PubMed ID: 15699836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
